Biophytis And SEQENS Enter Partnership To Produce Sarconeos (BIO101) Active Compound
Portfolio Pulse from Benzinga Newsdesk
Biophytis has entered into a partnership with SEQENS to produce Sarconeos (BIO101), an active compound. The partnership aims to enhance the production and supply of the compound.
July 18, 2023 | 5:29 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Biophytis' partnership with SEQENS for the production of Sarconeos (BIO101) could potentially enhance the company's product supply and market reach.
The partnership between Biophytis and SEQENS is directly related to the production of Sarconeos (BIO101), a product of Biophytis. This could potentially enhance the company's product supply and market reach, which could positively impact the company's stock in the short term.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100